Category Archives: Interventional Cardiology

CHICAGO, Dec. 11, 2019 /PRNewswire/ -- According to the new market research report "Contrast Media/Contrast Agent Marketby Type (Iodinated, Gadolinium, Barium and Microbubble), Procedure (X-Ray/CT, MRI and Ultrasound), Application (Radiology, Interventional Radiology and Interventional Cardiology), Region - Global Forecast to 2024", published by MarketsandMarkets, the Contrast Media/Contrast Agents Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, at a CAGR of 3.8% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 The key factors driving the growth of this market are increasing approvals for contrast agents and rising volume of CT & MRI examinations globally. Continue reading →

The Diagnostic Interventional Cardiology Devices Market report gives a purposeful depiction of the area by the practice for research, amalgamation, and review of data taken from various sources. The market analysts have displayed the different sidelines of the area with a point on recognizing the top players (B. Continue reading →

The industrial research report on Global Interventional Cardiology Devices market growth 2019-2024 published by MarketReports.co, the global and Chinese researchers are in-depth study on the present place of the Interventional Cardiology Devices organizations with main focus on the Chinese market. The report examines the major things countable for driving the growth of Interventional Cardiology Devices market 2019-2024, various factors like economic stability, lifting population, rapidly enhancing demand, developments and geographic regions, etc Continue reading →

Industry Report by Marketresearch.biz, Namely- Interventional Cardiology Devices Market provides a clear picture of the current market scenario which includes past and estimated future size with respect to value (Mn/Bn USD) and volume (x units), technological advancement, macro economical and governing factors in the Interventional Cardiology Devices market. The report scrutinizes the market into various segments, end uses, regions and players on the basis of demand pattern, and future prospects. Continue reading →

The ISCHEMIA trial had cardiologists' hearts skipping a beat long before it was presented at the American Heart Association (AHA) Scientific Sessions 2019 in Philadelphia last month. The hotly anticipated study, seen as a follow-on to the COURAGE trial, aimed to determine the best management strategy for high-risk patients with stable ischemic heart disease. Continue reading →

and Medtronic PLC Interventional Cardiology and Peripheral Vascular Devices Market: Segmentation Segmental analysis is one of the key sections of this report. Continue reading →

WOOSTER A banner dropped, and a celebration of Wooster Community Hospital itself becamea ceremony honoring its administrator of 25 years and counting. Hospital CEO Bill Sheron completed his presentation on the hospitals fifth time to win a Watson Health 100 Top Hospitals award in 2019 and became upstaged by Dan Wakefield, a member of the hospitals board of governors, introducing a program in Sherons honor. "We wanted to celebrate both (Sheron and the hospitals award)," said Scott Boyes, the hospitals chief financial and operating officer. Continue reading →

EASTON University of Maryland Shore Regional Health has appointed Gary Jones as the first director of the newly established Heart and Vascular Center at UM SRH. The alignment of the cardiology and vascular service lines as the Heart and Vascular Center reflects a standard practice across University of Maryland Medical System and reflects Shore Regional Healths comprehensive list of cardiovascular services. Jones most recently served as regional director, Cardiovascular Services Continue reading →

The Interventional Cardiology Market report gives an astonishing source to analyze the Interventional Cardiology market and other fundamental subtleties identifying with it. Continue reading →

WHEELING The structural heart team at Wheeling Hospital can now treat patients with severe mitral regurgitation who are at high risk for surgery, using a minimally invasive transcatheter mitral valve repair technology called the MitraClip. Mitral valve regurgitation is a condition in which the mitral valve does not close properly, allowing blood to leak back into the upper chamber on the left side of the heart. Continue reading →